BWAY
BrainsWay Ltd.
BWAY lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
BWAY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Stable | |
| Healthy |
BWAY's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BWAY PE Valuation
BWAY has no meaningful PE right now: it lost money over the past year.
BWAY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BWAY, with profitability improving. However, they disagree widely on these estimates.
BWAY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.37 | +147% |
| Q1 2026 | $0.28 | +133% |
| Q4 2025 | $0.18 | +80% |
| Q3 2025 | $0.15 | +114% |
| Q2 2025 | $0.15 | +650% |
| Q1 2025 | $0.12 | +$0.17 |
| Q4 2024 | $0.10 | +$0.22 |
| Q3 2024 | $0.07 | +$0.32 |
BWAY's earnings per share have climbed steadily: $0.37 over the past year, up 147% from the year before, and higher year over year for 12 quarters in a row.
BWAY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.4M | +38% |
| Q1 2026 | $15.5M | +35% |
| Q4 2025 | $14.5M | +27% |
| Q3 2025 | $13.5M | +29% |
| Q2 2025 | $12.6M | +26% |
| Q1 2025 | $11.5M | +27% |
| Q4 2024 | $11.4M | +26% |
| Q3 2024 | $10.5M | +26% |
BWAY's revenue has grown year over year for 12 quarters in a row: $17M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +9.4 points |
| Q1 2026 | 13% | +7.9 points |
| Q4 2025 | 13% | +9.4 points |
| Q3 2025 | 9.3% | +6.6 points |
| Q2 2025 | 4.6% | -1.3 points |
| Q1 2025 | 5% | +4 points |
| Q4 2024 | 3.8% | -108 points |
| Q3 2024 | 2.7% | +4.3 points |
BWAY's operating margin was 14% last quarter, up 9.4 points from the same quarter a year ago, near the top of its range since 2019.
BWAY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.5M | -51% |
| Q1 2026 | $402K | -90% |
| Q4 2025 | -$759K | -130% |
| Q3 2025 | $586K | -40% |
| Q2 2025 | $11.2M | +2139% |
| Q1 2025 | $4M | +62% |
| Q4 2024 | $2.6M | +27% |
| Q3 2024 | $978K | +16% |
BWAY still generates free cash flow, though less than at its 2025 peak: $6M over the past year.
BWAY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.5x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -5.2x | Net Cash |
| Q3 2025 | -6.6x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -10.0x | Net Cash |
| Q4 2024 | -11.9x | Net Cash |
| Q3 2024 | -8.6x | Net Cash |
BWAY has more cash than debt.
BWAY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 5.3 | Oversold |
BWAY's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
BWAY PE vs Healthcare Sector
| Metric | BWAY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BWAY has no meaningful PE right now: it lost money over the past year.
BWAY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.6 | 12% below |
| 20 week MA | $13.6 | 25% below |
| 50 week MA | $13.2 | 22% below |
| 100 week MA | $9.61 | 6.7% above |
| 200 week MA | $6.08 | 69% above |
BWAY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 69% above its 200-week average.
BWAY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.85 | $3.09 | -36% |
| 2021 | $3.09 | $3.76 | +22% |
| 2022 | $3.76 | $1.08 | -71% |
| 2023 | $1.08 | $3.24 | +200% |
| 2024 | $3.24 | $4.57 | +41% |
| 2025 | $4.57 | $9.69 | +112% |
| 2026 YTD | $9.69 | $10.3 | +5.8% |
BWAY's yearly returns have swung widely, from +200% in 2023 to −71% in 2022. It's up 5.8% so far in 2026.